Related references
Note: Only part of the references are listed.Androgen Deprivation Causes Epithelial-Mesenchymal Transition in the Prostate: Implications for Androgen-Deprivation Therapy
Yuting Sun et al.
CANCER RESEARCH (2012)
Correlation of ERG Expression and DNA Methylation Biomarkers with Adverse Clinicopathologic Features of Prostate Cancer
Ken Kron et al.
CLINICAL CANCER RESEARCH (2012)
Androgen deprivation therapy in combination with radiotherapy for high-risk clinically localized prostate cancer
Tsutomu Nishiyama
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2012)
Primary Xenografts of Human Prostate Tissue as a Model to Study Angiogenesis Induced by Reactive Stroma
Viviana P. Montecinos et al.
PLOS ONE (2012)
The multi-disciplinary management of high-risk prostate cancer
Jonathan C. Picard et al.
UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS (2012)
Radical Prostatectomy as Primary Treatment of High-risk Prostate Cancer
Alexandre Ingels et al.
CURRENT UROLOGY REPORTS (2012)
Primary human tumor xenografted models ('tumorgrafts') for good management of patients with cancer
Didier Decaudin
ANTI-CANCER DRUGS (2011)
Small Molecule Inhibitors Targeting the Achilles' Heel of Androgen Receptor Activity
Marianne D. Sadar
CANCER RESEARCH (2011)
Targeting Continued Androgen Receptor Signaling in Prostate Cancer
Christophe Massard et al.
CLINICAL CANCER RESEARCH (2011)
New Strategies in Metastatic Prostate Cancer: Targeting the Androgen Receptor Signaling Pathway
Gerhardt Attard et al.
CLINICAL CANCER RESEARCH (2011)
Novel agents and new therapeutics in castration-resistant prostate cancer
Yichao Wu et al.
CURRENT OPINION IN ONCOLOGY (2011)
A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer
Manuel Hidalgo et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Hormone Depletion-Insensitivity of Prostate Cancer Cells Is Supported by the AR Without Binding to Classical Response Elements
Mesfin Gonit et al.
MOLECULAR ENDOCRINOLOGY (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Epithelial-to-mesenchymal transition in prostate cancer: paradigm or puzzle?
Jones T. Nauseef et al.
NATURE REVIEWS UROLOGY (2011)
Targeting 5α-reductase for prostate cancer prevention and treatment
Lucas P. Nacusi et al.
NATURE REVIEWS UROLOGY (2011)
Tissue Slice Grafts An in Vivo Model of Human Prostate Androgen Signaling
Hongjuan Zhao et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Tuberin Regulates E-Cadherin Localization Implications in Epithelial-Mesenchymal Transition
Elizabeth A. Barnes et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Site-Dependent E-Cadherin Cleavage and Nuclear Translocation in a Metastatic Colorectal Cancer Model
Maria Virtudes Cespedes et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
Michel Bolla et al.
LANCET ONCOLOGY (2010)
Epithelial to Mesenchymal Transition Is Mechanistically Linked with Stem Cell Signatures in Prostate Cancer Cells
Dejuan Kong et al.
PLOS ONE (2010)
Androgen Receptor Regulates a Distinct Transcription Program in Androgen-Independent Prostate Cancer
Qianben Wang et al.
CELL (2009)
Androgen Deprivation Therapy for the Treatment of Prostate Cancer: Consider Both Benefits and Risks
Hendrik Isbarn et al.
EUROPEAN UROLOGY (2009)
Growth analysis of the mouse adrenal gland from weaning to adulthood: time- and gender-dependent alterations of cell size and number in the cortical compartment
Max Bielohuby et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma
M. E. Prince et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Biology of progressive, castration-resistant prostate cancer: Directed therapies targeting the androgen-receptor signaling axis
HI Scher et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Development and characterization of efficient xenograft models for benign and malignant human prostate-tissue
YZ Wang et al.
PROSTATE (2005)
Short-term human prostate primary xenografts:: An in vivo model of human prostate cancer vasculature and angiogenesis
DR Gray et al.
CANCER RESEARCH (2004)
Evidence of pluripotent human prostate stem cells in a human prostate primary xenograft model
WJ Huss et al.
PROSTATE (2004)
Molecular determinants of resistance to antiandrogen therapy
CD Chen et al.
NATURE MEDICINE (2004)
The influence of androgen deprivation therapy on dihydrotestosterone levels in the prostatic tissue of patients with prostate cancer
T Nishiyama et al.
CLINICAL CANCER RESEARCH (2004)
A new xenograft model for graft-versus-host disease by intravenous transfer of human peripheral blood mononuclear cells in RAG2-/- γc-/- double-mutant mice
RS van Rijn et al.
BLOOD (2003)
Pathological effects of neoadjuvant hormonal therapy help predict progression of prostate cancer after radical prostatectomy
Y Kitagawa et al.
INTERNATIONAL JOURNAL OF UROLOGY (2003)
Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era
AV D'Amico et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Quantitation of apoptotic activity following castration in human prostatic tissue in vivo
A Staack et al.
PROSTATE (2003)
Determinants of prostate cancer-specific survival after radiation therapy for patients with clinically localized prostate cancer
AV D'Amico et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Recent insights into organogenesis of the adrenal cortex
CE Keegan et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2002)
Establishment of short-term primary human prostate xenografts for the study of prostate biology and cancer
SC Presnell et al.
AMERICAN JOURNAL OF PATHOLOGY (2001)